Ana B. Rossi

3.4k total citations · 2 hit papers
95 papers, 2.1k citations indexed

About

Ana B. Rossi is a scholar working on Dermatology, Immunology and Allergy and Physiology. According to data from OpenAlex, Ana B. Rossi has authored 95 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 87 papers in Dermatology, 53 papers in Immunology and Allergy and 35 papers in Physiology. Recurrent topics in Ana B. Rossi's work include Dermatology and Skin Diseases (70 papers), Allergic Rhinitis and Sensitization (42 papers) and Asthma and respiratory diseases (32 papers). Ana B. Rossi is often cited by papers focused on Dermatology and Skin Diseases (70 papers), Allergic Rhinitis and Sensitization (42 papers) and Asthma and respiratory diseases (32 papers). Ana B. Rossi collaborates with scholars based in United States, France and Germany. Ana B. Rossi's co-authors include André Luiz Vergnanini, Antony R. Young, Joël Claveau, Eric L. Simpson, Laurent Eckert, Jonathan I. Silverberg, Michael J. Cork, Abhijit Gadkari, C. Bertin and Kenji Kabashima and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and PEDIATRICS.

In The Last Decade

Ana B. Rossi

89 papers receiving 2.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Atopic dermatitis in the pediatric population

2021 255 citations Jonathan I. Silverberg, S. Barbarot et al. profile →
Type 2 Inflammation Contributes to Skin Barrier Dysfunction in Atopic Dermatitis

2022 139 citations Lisa A. Beck, Michael J. Cork et al. SHILAP Revista de lepidopterología profile →

Peers

Countries citing papers authored by Ana B. Rossi

Since Specialization

Citations

This map shows the geographic impact of Ana B. Rossi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ana B. Rossi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ana B. Rossi more than expected).

Fields of papers citing papers by Ana B. Rossi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ana B. Rossi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ana B. Rossi. The network helps show where Ana B. Rossi may publish in the future.

Co-authorship network of co-authors of Ana B. Rossi

This figure shows the co-authorship network connecting the top 25 collaborators of Ana B. Rossi. A scholar is included among the top collaborators of Ana B. Rossi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ana B. Rossi. Ana B. Rossi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	The Safety Data of Dupilumab for the Treatment of Moderate‑to‑Severe Atopic Dermatitis in Infants, Children, Adolescents, and Adults 2025 ·American Journal of Clinical Dermatology ·Richard G. Langley, (unknown), Anna Coleman, Marius Ardeleanu, (unknown), (unknown), Ashish Bansal, Zhen Chen, Ana B. Rossi, Brad Shumel, Faisal A. Khokhar	0
2	Dupilumab versus Lebrikizumab Demonstrates Greater Likelihood of Achieving and Maintaining Improvements in Efficacy Outcomes Using a Placebo-Adjusted Indirect Treatment Comparison 2025 ·Dermatology and Therapy ·Sonja Ständer, Andreas Pinter, (unknown), Patricia Guyot, Yingxin Xu, Amy Praestgaard, Nick Freemantle, Ana B. Rossi, (unknown), Zhixiao Wang, (unknown), (unknown)	1
3	Dupilumab demonstrates improvements in biomarker levels across racial subgroups in pediatric patients with moderate-to-severe atopic dermatitis 2023 ·Revue française d'allergologie ·(unknown), Candrice Heath, (unknown), (unknown), Ana B. Rossi, (unknown), (unknown), (unknown), (unknown)	1
4	Dupilumab Provides Rapid and Sustained Improvement in SCORing Atopic Dermatitis Outcomes in Paediatric Patients with Atopic Dermatitis 2022 ·Acta Dermato Venereologica ·Andreas Wollenberg, Danielle Marcoux, Jonathan I. Silverberg, Valéria Aoki, Eulàlia Baselga, Haixin Zhang, Noah A. Levit, Alain Taı̈eb, Ana B. Rossi	8
5	Dupilumab Treatment in Adults with Moderate-to-Severe Atopic Dermatitis is Efficacious Regardless of Age of Disease Onset: a Post Hoc Analysis of Two Phase 3 Clinical Trials 2022 ·Dermatology and Therapy ·Jonathan I. Silverberg, Mark Boguniewicz, Jon M. Hanifin, Kim Papp, Haixin Zhang, Ana B. Rossi, Noah A. Levit	7
6	Dupilumab significantly improves skin barrier function in patients with moderate‐to‐severe atopic dermatitis 2022 ·Allergy ·Evgeny Berdyshev, Elena Goleva, Robert Bissonnette, Irina Bronova, (unknown), Brittany Richers, (unknown), Marco Ramírez-Gama, Patricia A. Taylor, Amy Praestgaard, Inoncent Agueusop, (unknown), Mark Boguniewicz, Noah A. Levit, Ana B. Rossi, Annie Zhang, Donald Y.M. Leung	77
7	Type 2 Inflammation Contributes to Skin Barrier Dysfunction in Atopic Dermatitis breakdown → 2022 ·SHILAP Revista de lepidopterología ·Lisa A. Beck, Michael J. Cork, Masayuki Amagai, Anna De Benedetto, Kenji Kabashima, Jennifer D. Hamilton, Ana B. Rossi	139
8	The Family Impact of Atopic Dermatitis in the Pediatric Population: Results from an International Cross-sectional Study 2022 ·The Journal of Pediatrics ·S. Barbarot, (unknown), Abhijit Gadkari, Eric L. Simpson, Stephan Weidinger, Paola Mina‐Osorio, Ana B. Rossi, Lysel Brignoli, (unknown), Isabelle Guillemin, Miriam C. Fenton, (unknown), Puneet Mahajan, Dimittri Delevry, Ashish Bansal, Laurent Eckert	30
9	Dupilumab Treatment Provides Sustained Improvements Over 2 Years in Symptoms and Quality of Life in Adults with Atopic Dermatitis 2021 ·Dermatology and Therapy ·Gil Yosipovitch, Marjolein de Bruin‐Weller, April W. Armstrong, Jashin J. Wu, Pedro Herranz, Diamant Thaçi, Dimittri Delevry, (unknown), (unknown), Brad Shumel, Ana B. Rossi, Jingdong Chao	7
10	IGAxBSA composite for assessing disease severity and response in patients with atopic dermatitis* 2021 ·British Journal of Dermatology ·Amy S. Paller, Jerry Tan, Jerry Bagel, Ana B. Rossi, Brad Shumel, (unknown), (unknown)	8
11	Efficacy of Dupilumab in Atopic Dermatitis: The Patient’s Perspective 2021 ·Dermatology and Therapy ·Marjolein de Bruin‐Weller, Joseph F. Merola, Chih-ho Hong, (unknown), Karel Ettler, Debra Sierka, Dimittri Delevry, Zhen Chen, Ana B. Rossi	1
12	Dupilumab in Adults with Moderate-to-Severe Atopic Dermatitis and Prior Use of Systemic Non-Steroidal Immunosuppressants: Analysis of Four Phase 3 Trials 2021 ·Dermatology and Therapy ·C.E.M. Griffiths, Marjolein de Bruin‐Weller, Mette Deleuran, Maria Concetta Fargnoli, D. Staumont‐Sallé, Chih-ho Hong, (unknown), Peter Foley, Seong Jun Seo, Jérôme Msihid, Zhen Chen, Sonya Cyr, Ana B. Rossi	21
13	Dupilumab Improves Outcomes of Concurrent Asthma and Chronic Sino-Nasal Conditions in Patients With Atopic Dermatitis—a Pooled Analysis of Four Phase 3 Studies (LIBERTY AD SOLO 1 & 2, CHRONOS, and CAFÉ) 2019 ·Journal of Allergy and Clinical Immunology ·Mark Boguniewicz, Diamant Thaçi, Peter Lio, Thomas Hultsch, Ana B. Rossi, Laurent Eckert, Abhijit Gadkari, Brad Shumel, Qiuyue Chen, Zhen Chen, Marius Ardeleanu	4
14	Laboratory safety of dupilumab in moderate-to-severe atopic dermatitis: results from three phase III trials (LIBERTY AD SOLO 1, LIBERTY AD SOLO 2, LIBERTY AD CHRONOS) 2019 ·British Journal of Dermatology ·Andreas Wollenberg, Lisa A. Beck, Andrew Blauvelt, Eric L. Simpson, Z. Chen, (unknown), Brad Shumel, Faisal A. Khokhar, Thomas Hultsch, E. Rizova, Ana B. Rossi, Neil M.H. Graham, Gianluca Pirozzi, Yuan Lü, Marius Ardeleanu	91
15	In situ antioxidant activity of a dermo‐cosmetic product: A randomized controlled clinical study 2019 ·Experimental Dermatology ·(unknown), Vincenzo Nobile, Ana B. Rossi	8
16	Dupilumab provides important clinical benefits to patients with atopic dermatitis who do not achieve clear or almost clear skin according to the Investigator's Global Assessment: a pooled analysis of data from two phase III trials 2019 ·British Journal of Dermatology ·Jonathan I. Silverberg, Eric L. Simpson, Marius Ardeleanu, Diamant Thaçi, S. Barbarot, Jerry Bagel, Z. Chen, Laurent Eckert, J. Chao, Andrew Korotzer, E. Rizova, Ana B. Rossi, Yuan Lü, (unknown), Thomas Hultsch, Gianluca Pirozzi, Bolanle Akinlade	44
17	Clinically Meaningful Responses to Dupilumab in Adolescents with Uncontrolled Moderate-to-Severe Atopic Dermatitis: Post-hoc Analyses from a Randomized Clinical Trial 2019 ·American Journal of Clinical Dermatology ·Amy S. Paller, Ashish Bansal, Eric L. Simpson, Mark Boguniewicz, Andrew Blauvelt, Elaine C. Siegfried, Emma Guttman‐Yassky, Thomas Hultsch, Zhen Chen, Paola Mina‐Osorio, Yufang Lü, Ana B. Rossi, Xinyi He, Mohamed Kamal, Neil M.H. Graham, Gianluca Pirozzi, Marcella Ruddy, Laurent Eckert, Abhijit Gadkari	55
18	A novel dermo-cosmetic product containing thermal spring water, sucralfate, copper sulfate, and zinc sulfate in the management of hand eczema 2018 ·Clinical Cosmetic and Investigational Dermatology ·(unknown), (unknown), Anne Sîrvent, Victor Georgescu, Ana B. Rossi	9
19	Rivers shape population genetic structure in Mauritia flexuosa (Arecaceae) 2018 ·Ecology and Evolution ·(unknown), (unknown), Carolina Joana da Silva, (unknown), María Teresa Pulido Silva, Marco Antônio Aparecido Barelli, Ana B. Rossi, Alexandre Pio Viana, (unknown), Christine D. Bacon, Angélica Cibrián‐Jaramillo	16
20	Topical immunotherapy of alopecia areata. A follow-up study 1986 ·Acta Dermato Venereologica ·R. Valsecchi, T. Cainelli, (unknown), Ana B. Rossi	21

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact